{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:53:28Z","timestamp":1791636808501,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET 2449235"],"award-info":[{"award-number":["CBET 2449235"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014726","name":"National Institute for Innovation in Manufacturing Biopharmaceuticals","doi-asserted-by":"publisher","award":["PC8.1-135"],"award-info":[{"award-number":["PC8.1-135"]}],"id":[{"id":"10.13039\/100014726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014726","name":"National Institute for Innovation in Manufacturing Biopharmaceuticals","doi-asserted-by":"publisher","award":["PC9.1-105"],"award-info":[{"award-number":["PC9.1-105"]}],"id":[{"id":"10.13039\/100014726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["R01FD007481"],"award-info":[{"award-number":["R01FD007481"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.chroma.2026.467470","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:23:40Z","timestamp":1789914220000},"page":"467470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Going with the flow: peptide affinity membranes for high-throughput, high-yield purification of adenovirus and lentiviral vectors"],"prefix":"10.1016","volume":"1788","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4988-1123","authenticated-orcid":false,"given":"Yuxuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-9567","authenticated-orcid":false,"given":"Arianna","family":"Minzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7541-3653","authenticated-orcid":false,"given":"Aishwarya","family":"Gangadhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4829-2087","authenticated-orcid":false,"given":"Eduardo","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4173-632X","authenticated-orcid":false,"given":"Irfan","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8434-7738","authenticated-orcid":false,"given":"Luke","family":"Remmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2016-4091","authenticated-orcid":false,"given":"Michael A.","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-434X","authenticated-orcid":false,"given":"Stefano","family":"Menegatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2026.467470_bib0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0734-9750(02)00030-7","article-title":"Production of adenovirus vector for gene therapy","volume":"20","author":"Nadeau","year":"2003","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.chroma.2026.467470_bib0002","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/ijms21103643","article-title":"High-capacity adenoviral vectors: expanding the scope of gene therapy","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2026.467470_bib0003","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2014","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0004","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/pharmaceutics14081605","article-title":"Lentiviral vectors for ocular gene therapy","volume":"14","author":"Arsenijevic","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chroma.2026.467470_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/gt.2011.153","article-title":"Ocular gene delivery using lentiviral vectors","volume":"19","author":"Balaggan","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0006","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","article-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study, hum","volume":"28","author":"Campochiaro","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0007","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/1078-0432.CCR-09-3167","article-title":"Oncolytic Adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors","volume":"16","author":"Nokisalmi","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chroma.2026.467470_bib0008","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chroma.2026.467470_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40267-024-01045-0","article-title":"Nadofaragene firadenovec in high-risk Bacillus Calmette Gu\u00e9rin unresponsive non-muscle invasive bladder cancer: a profile of its use","volume":"40","author":"Nie","year":"2024","journal-title":"Drugs Ther. Perspect."},{"key":"10.1016\/j.chroma.2026.467470_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.104624","article-title":"Zynteglo: Betibeglogene autotemcel \u2013 an innovative therapy for \u03b2- thalassemia patients","volume":"82","author":"Asghar","year":"2022","journal-title":"Ann. Medicine Surg."},{"key":"10.1016\/j.chroma.2026.467470_bib0011","series-title":"CAR-T-Cell Therapy: Success and Advancements in the Treatment of Hematological Malignancies, in: Cell-Based Immunotherapies For Cancer","first-page":"127","author":"Hegde","year":"2025"},{"key":"10.1016\/j.chroma.2026.467470_bib0012","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1182\/blood-2024-201606","article-title":"Efficacy of Carvykti in cartitude-4 versus alternative treatments from Daratumumab clinical trials for the treatment of patients with lenalidomide-refractory multiple myeloma","volume":"144","author":"Delforge","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.chroma.2026.467470_bib0013","article-title":"Process Systems engineering in Precision medicine: opportunities in autologous CAR-T therapy","volume":"26","author":"Bequette","year":"2026","journal-title":"Eng. Life Sci."},{"key":"10.1016\/j.chroma.2026.467470_bib0014","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bbrc.2005.03.227","article-title":"Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration","volume":"331","author":"Ugai","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chroma.2026.467470_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465396","article-title":"Peptide ligands for the affinity purification of adenovirus from HEK293 and vero cell lysates","volume":"1736","author":"Wu","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467470_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nprot.2006.37","article-title":"Production and purification of lentiviral vectors","volume":"1","author":"Tiscornia","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chroma.2026.467470_bib0017","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14712598.2013.779249","article-title":"New developments in lentiviral vector design, production and purification","volume":"13","author":"Segura","year":"2013","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0018","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/vaccines9080823","article-title":"Critical assessment of purification and analytical technologies for enveloped viral vector and vaccine processing and their current limitations in resolving co-expressed extracellular vesicles","volume":"9","author":"Minh","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.chroma.2026.467470_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.17","article-title":"Production of lentiviral vectors","volume":"3","author":"Merten","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.chroma.2026.467470_bib0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1634\/theoncologist.7-1-46","article-title":"Adenoviral gene therapy","volume":"7","author":"Vorburger","year":"2002","journal-title":"Oncologist."},{"key":"10.1016\/j.chroma.2026.467470_bib0021","doi-asserted-by":"crossref","DOI":"10.3791\/52894","article-title":"Cloning and large-scale production of high-capacity adenoviral vectors based on the Human Adenovirus type 5","author":"Ehrke-Schulz","year":"2016","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/j.chroma.2026.467470_bib0022","series-title":"Adenovirus: Methods and Protocols","first-page":"159","article-title":"Construction, production, and purification of recombinant adenovirus vectors","author":"Miravet","year":"2013"},{"key":"10.1016\/j.chroma.2026.467470_bib0023","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sj.gt.3302611","article-title":"Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications","volume":"12","author":"Burova","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0024","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1021\/acs.analchem.9b04328","article-title":"Use of super-resolution optical microscopy to reveal direct virus binding at hybrid core\u2013Shell matrixes","volume":"92","author":"Gast","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467470_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/hgtb.2019.172","article-title":"Nanoparticle tracking of Adenovirus by light scattering and fluorescence detection, hum","volume":"30","author":"Gast","year":"2019","journal-title":"Gene Ther. Methods"},{"key":"10.1016\/j.chroma.2026.467470_bib0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jbiotec.2022.11.015","article-title":"An efficient capture strategy for the purification of human adenovirus type 5 from cell lysates","volume":"361","author":"Dietl","year":"2023","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.chroma.2026.467470_bib0027","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.3390\/ijms24043354","article-title":"Implementation of novel affinity ligand for lentiviral vector purification","volume":"24","author":"Moreira","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2026.467470_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464337","article-title":"The downstream bioprocess toolbox for therapeutic viral vectors","volume":"1709","author":"Kilgore","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467470_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466557","article-title":"Integrating the affinity and anion-exchange purification of AAV8: how the selective enrichment of full capsids at the affinity capture step enhances the downstream processing of gene therapies","volume":"1765","author":"Shastry","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467470_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.70017","article-title":"Developing a process of lentivirus purification from recombinant fluids using peptide affinity ligands","volume":"10","author":"Barbieri","year":"2025","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.chroma.2026.467470_bib0032","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/bit.28594","article-title":"Peptide ligands targeting the vesicular stomatitis virus G (VSV-G) protein for the affinity purification of lentivirus particles","volume":"121","author":"Barbieri","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2026.467470_bib0033","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/bit.28495","article-title":"Peptide ligands for the affinity purification of adeno-associated viruses from HEK 293 cell lysates","volume":"120","author":"Chu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2026.467470_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300230","article-title":"Rational design and experimental evaluation of peptide ligands for the purification of adeno-associated viruses via affinity chromatography","volume":"19","author":"Shastry","year":"2024","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.chroma.2026.467470_bib0035","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/bit.29006","article-title":"Integrating affinity chromatography in the platform process for Adenovirus purification","volume":"122","author":"Wu","year":"2025","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2026.467470_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464194","article-title":"Continuous multi-membrane chromatography of large viral particles","volume":"1705","author":"Matos","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2026.467470_bib0037","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ces.2018.03.041","article-title":"Transport properties and size exclusion effects in wide-pore superficially porous particles","volume":"185","author":"Maier","year":"2018","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.chroma.2026.467470_bib0038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coche.2011.08.008","article-title":"Downstream bioprocessing: recent advances and future promise","volume":"1","author":"Cramer","year":"2011","journal-title":"Curr. Opin. Chem. Eng."},{"key":"10.1016\/j.chroma.2026.467470_bib0039","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00216-022-04325-8","article-title":"Recent development and application of membrane chromatography","volume":"415","author":"Chen","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2026.467470_bib0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/pr8070799","article-title":"Recent insights into lignocellulosic biomass pyrolysis: a critical review on pretreatment, characterization, and products upgrading","volume":"8","author":"Zadeh","year":"2020","journal-title":"Processes"},{"key":"10.1016\/j.chroma.2026.467470_bib0041","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/polym11010127","article-title":"Description of the resin curing process\u2014formulation and optimization","volume":"11","author":"Muc","year":"2019","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.chroma.2026.467470_bib0042","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1089\/104303402320139014","article-title":"Scalable purification of Adeno-associated Virus type 2, 4, or 5 using ion-exchange chromatography","volume":"13","author":"Kaludov","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0043","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1525-0016(02)90719-7","article-title":"A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5","volume":"6","author":"Brument","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0044","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/hum.1997.8.4-453","article-title":"Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles","volume":"8","author":"Shabram","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0045","article-title":"Development of a cGMP-ready purification process for adenovirus purification","volume":"6720","author":"Fitchmun","year":"2015","journal-title":"Bio-Rad Lab. Bull."},{"key":"10.1016\/j.chroma.2026.467470_bib0046","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ab.2005.11.014","article-title":"Quantitation of adenovirus type 5 empty capsids","volume":"349","author":"Takahashi","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2026.467470_bib0047","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(93)90382-Z","article-title":"Stepwise dismantling of adenovirus 2 during entry into cells","volume":"75","author":"Greber","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.chroma.2026.467470_bib0048","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/v13020268","article-title":"Lentiviral vector bioprocessing","volume":"13","author":"Perry","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.chroma.2026.467470_bib0049","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/B978-0-12-386509-0.00003-X","article-title":"Retrovirus and lentivirus vector design and methods of cell conditioning","volume":"507","author":"Cooray","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.chroma.2026.467470_bib0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jgm.1022","article-title":"Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors\u2014 in vitro and in vivo implications","volume":"9","author":"Farley","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.chroma.2026.467470_bib0051","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/biomedicines14020369","article-title":"Challenges and opportunities in lentivirus viral vector manufacturing for In vivo applications","volume":"14","author":"Barbieri","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.chroma.2026.467470_bib0052","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/mthe.2000.0116","article-title":"VSV-G pseudotyped lentiviral vector particles produced in Human cells are inactivated by Human serum","volume":"2","author":"DePolo","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0053","unstructured":"Grant D. Trobridge, Hans-Peter Kiem, Cocal vesiculovirus envelope pseudotyped retroviral vectors, US20120164118A1, 2010."},{"key":"10.1016\/j.chroma.2026.467470_bib0054","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/mt.2009.282","article-title":"Cocal-pseudotyped lentiviral vectors resist inactivation by Human serum and efficiently transduce primate hematopoietic repopulating cells","volume":"18","author":"Trobridge","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0055","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2023-187488","article-title":"CD90-Targeted cocal-pseudotyped lentivirus As a robust platform for Human HSC gene therapy","volume":"142","author":"Thomas","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.chroma.2026.467470_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3286","article-title":"Evaluation of lentiviral vector stability and development of ion exchange purification processes","volume":"38","author":"Ghosh","year":"2022","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.chroma.2026.467470_bib0057","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.70102","article-title":"Enhanced lentiviral vector recovery and separation using arginine hydrochloride with CIM QA monoliths","volume":"42","author":"Kocot","year":"2026","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.chroma.2026.467470_bib0058","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omtm.2019.08.007","article-title":"Lentiviral vector purification using nanofiber ion-exchange chromatography","volume":"15","author":"Ruscic","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2026.467470_bib0059","article-title":"Evaluation of lentiviral vector stability and development of an ion exchange purification process","volume":"3584","year":"2023","journal-title":"Bio-Rad Lab. Bull."},{"key":"10.1016\/j.chroma.2026.467470_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101533","article-title":"Membrane adsorber design for lentiviral vector recovery","volume":"33","author":"Pamenter","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2026.467470_bib0061","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41434-019-0085-4","article-title":"AAV9 Vector: a novel modality in gene therapy for spinal muscular atrophy","volume":"26","author":"Pattali","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.chroma.2026.467470_bib0062","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.chroma.2026.467470_bib0063","doi-asserted-by":"crossref","first-page":"9204","DOI":"10.3390\/ijms24119204","article-title":"Safety and efficacy of intravenous and intrathecal delivery of AAV9-mediated ARSA in minipigs","volume":"24","author":"Mullagulova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2026.467470_bib0065","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1021\/acs.iecr.7b00631","article-title":"Ultrafiltration membranes enhanced with electrospun nanofibers exhibit improved flux and fouling resistance","volume":"56","author":"Dobosz","year":"2017","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.chroma.2026.467470_bib0066","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/membranes1030249","article-title":"Functionality in electrospun nanofibrous membranes based on Fiber\u2019s size, surface area, and molecular orientation","volume":"1","author":"Matsumoto","year":"2011","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.chroma.2026.467470_bib0067","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.omtm.2020.03.025","article-title":"Development of large-scale downstream processing for lentiviral vectors","volume":"17","author":"Valkama","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2026.467470_bib0068","article-title":"Gene therapy loses luster as investors eye quicker returns from weight-loss drugs","author":"Patton","year":"2025","journal-title":"Reuters"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002196732600796X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002196732600796X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:07:46Z","timestamp":1791634066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002196732600796X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":66,"alternative-id":["S002196732600796X"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467470","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Going with the flow: peptide affinity membranes for high-throughput, high-yield purification of adenovirus and lentiviral vectors","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"467470"}}